Taiping Healthcare Fund
太平医疗健康基金
Taiping Healthcare Fund (太平医疗健康基金) appears only once in elsewhere's corpus: in July 2026 it led the Series A round of Jianda Jiuzhou (GenAns Tech), a Beijing biotech working on precision therapies for brain science and ophthalmology — a deal worth hundreds of millions of RMB, with existing shareholder Huatai Zijin's fund doubling down and Gaorong Venture Capital among the participating investors, per Gaorong's announcement . Beyond that single deal, the corpus carries no profile of the fund itself — its founding, size, or strategy are not covered here, though its name suggests an affiliation with China Taiping, which elsewhere also does not substantiate in this material.
AI-generated — may contain errors, please verify.
Coverage
Gaorong Ventures Report: Physical AI, Domestic Computing Power, Controllable Nuclear Fusion, and Medical Innovation Companies Close Major Funding Rounds
From the continuous leap in model capabilities to hard tech crossing the thresholds of engineering and industrialization, a new wave of technological innovation is accelerating toward the real world.
Jianda Jiuzhou Closes Hundreds of Millions of RMB in Series A Funding, Cementing Global Leadership in Precision Therapies for Brain Science and Ophthalmology
Accelerating the market launch of precision therapies for brain diseases.
Andon Therapeutics Raises Over 400 Million Yuan in Series C Funding to Accelerate Phase III Clinical Trials for Revolutionary Pan-Anemia Drug
Focused on R&D of novel drugs for kidney diseases, pan-anemia conditions, and cancer.
Autumn's Prime: Six FreeS Fund Early-Stage Portfolio Companies Raise Nearly 1 Billion RMB | FreeS Family Funding News Vol.15
Looking forward to working alongside more outstanding founders.
